Abcellera Biologics shares owned by Cedar Brook Financial Partners
Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Cedar Brook Financial Partners
from 13F filings
Historical chart of Cedar Brook Financial Partners investment in Abcellera Biologics
Tip: Access up to 7 years of quarterly data
All positions including Abcellera Biologics held by Cedar Brook Financial Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Abcellera Biologics by Cedar Brook Financial Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $180k | 40k | 4.53 |
| 2023-12-31 | $216k | 40k | 5.45 |
| 2023-09-30 | $139k | 30k | 4.60 |
| 2023-06-30 | $163k | 25k | 6.46 |
| 2023-03-31 | $181k | 24k | 7.54 |
| 2022-12-31 | $243k | 24k | 10.13 |
| 2022-09-30 | $217k | 22k | 9.89 |
| 2022-06-30 | $223k | 21k | 10.64 |
| 2022-03-31 | $165k | 17k | 9.73 |
| 2021-12-31 | $168k | 12k | 14.34 |
More positions owned by Cedar Brook Financial Partners
View all positions for Cedar Brook Financial Partners